GLP-1 Weight Loss Medications: What They Cost Without Insurance in 2026

June 4, 2026 · Cost Guide · 6 min read

GLP-1 receptor agonists — including semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — retail at $900–$1,400 per month without insurance. For most patients without coverage, compounded versions from licensed pharmacies at $200–$600/month are the primary access point. This guide breaks down actual 2026 pricing for every GLP-1 option, the cost of getting a prescription, and the realistic paths to reducing what you pay.

Brand-Name GLP-1 Retail Prices Without Insurance (2026)

These are current retail prices at major U.S. pharmacies without insurance or discount cards:

• Wegovy (semaglutide 2.4mg, Novo Nordisk): $1,349/month — FDA-approved specifically for chronic weight management. Available in 0.25mg, 0.5mg, 1.0mg, 1.7mg, and 2.4mg doses for the titration schedule.
• Zepbound (tirzepatide, Eli Lilly): $1,059/month — FDA-approved for weight management. Tirzepatide acts on both GLP-1 and GIP receptors; clinical trials showed average weight loss of 20–22% of body weight, higher than semaglutide's 14–16%.
• Ozempic (semaglutide 0.5–2.0mg, Novo Nordisk): $936/month — FDA-approved for type 2 diabetes, frequently prescribed off-label for weight loss. Same active ingredient as Wegovy but at lower doses and without the weight management indication.
• Mounjaro (tirzepatide, Eli Lilly): $1,069/month — FDA-approved for type 2 diabetes, same active ingredient as Zepbound. Often prescribed off-label for weight loss when Zepbound has availability or coverage issues.
• Saxenda (liraglutide 3.0mg, Novo Nordisk): $1,349/month — the original FDA-approved weight loss GLP-1, now largely superseded by more effective semaglutide and tirzepatide options. Still in use for patients who tolerate liraglutide well.
• Victoza (liraglutide 1.2–1.8mg, Novo Nordisk): $600–$700/month — diabetes-indicated liraglutide at lower doses than Saxenda.

Compounded GLP-1 Medications: What They Cost and What to Know

Compounded semaglutide and tirzepatide are produced by licensed 503A (patient-specific) and 503B (outsourcing facility) compounding pharmacies. They became widely available after Novo Nordisk and Eli Lilly couldn't meet demand during 2023–2025 shortage periods. In 2026, brand-name supply has largely normalized, but compounders remain active because the price differential is substantial:

• Compounded semaglutide (injectable): $250–$600/month depending on dose and pharmacy
• Compounded tirzepatide (injectable): $200–$550/month depending on dose and pharmacy
• Compounded semaglutide (oral tablets, newer formulation): $150–$400/month from some compounders; bioavailability data is less established than injectable

Compounded versions are not FDA-approved drugs and are not required to meet the same manufacturing standards as brand-name products. Reputable compounders operate under state pharmacy board oversight and should provide a certificate of analysis (CoA) for each batch confirming the active ingredient concentration. Always verify your compounder's license at your state pharmacy board and ask specifically for a CoA.

Telehealth Weight Loss Platforms: Bundled Costs

Several telehealth platforms have built subscription models that bundle provider visits, prescription management, and often the medication itself:

• Ro Body: $99–$145/month for the platform subscription (consultation and clinical support), plus medication cost. They source both brand-name and compounded options depending on eligibility and coverage.
• Found: $99/month for care coordination. Medications billed separately — they work with insurance and cash-pay compounders.
• WeightWatchers Clinic: Platform subscription + medical visit included; medication billed separately or through insurance.
• Calibrate: $250/month program fee includes provider visits and coaching; medication prescribed but billed separately.

Telehealth platforms often provide faster access to a GLP-1 prescription (sometimes within 48–72 hours) compared to waiting for a primary care appointment. The tradeoff is that ongoing clinical oversight is remote rather than in-person, which may matter for patients with comorbidities.

The Cost of Getting Prescribed

GLP-1 medications require a prescription. The upfront cost to qualify and get prescribed:

• Primary care visit: $150–$300 without insurance for a new patient appointment. Established patients may have this covered under preventive care. See our guide on what a doctor visit costs without insurance.
• Required bloodwork: Most prescribers require a metabolic panel (HbA1c, lipid panel, kidney/liver function) before prescribing. Lab costs: $100–$300 without insurance. See our breakdown of lab test costs without insurance.
• Obesity medicine specialist: $200–$450 for a new patient consultation, though these specialists often have shorter waitlists than primary care due to dedicated scheduling for weight management.
• Monthly follow-up visits: $75–$175 per visit without insurance; most prescribers require monthly check-ins for at least the first 6 months.

Total first-year cost without insurance for a GLP-1 medication approach: $12,000–$18,000 for brand-name options, or $4,500–$9,000 using compounded medications — before any discounts.

How to Reduce GLP-1 Costs

Manufacturer Savings Cards (Commercially Insured Only)

Novo Nordisk's Wegovy savings program and Eli Lilly's Zepbound savings card can reduce copays to $25 or less per month for commercially insured patients. These programs do not apply to Medicare, Medicaid, or uninsured patients. Verify current program terms directly with each manufacturer — eligibility thresholds and maximum monthly savings change periodically.

GoodRx and Pharmacy Discount Cards

GoodRx and similar cards typically reduce prices 5–15% at major pharmacy chains — helpful for other medications, but GLP-1s are high-cost drugs where manufacturers control pricing tightly. GoodRx prices for Wegovy and Zepbound in early 2026 were only marginally below retail list. The discounts are more meaningful at independent pharmacies.

Insurance Prior Authorization: Worth Fighting For

If your insurance covers GLP-1 medications with prior authorization, the process involves your prescriber documenting your BMI (typically must be 30+, or 27+ with a weight-related comorbidity), prior weight loss attempts, and clinical necessity. Initial denials are common — but appeals succeed roughly 40–60% of the time when supported by adequate clinical documentation. Your prescriber's office should handle the appeal; if they won't, obesity medicine specialists are more experienced with this process than general practitioners. See our guide on how to appeal a health insurance denial.

Switching to the Diabetes-Indicated Version

Ozempic and Mounjaro are the same active ingredients as Wegovy and Zepbound respectively, at generally lower or equivalent doses, with diabetes indications. Some insurance plans cover the diabetes-indicated versions under pharmacy benefits but exclude the weight loss-indicated versions. Whether this approach is clinically appropriate and legally prescribable depends on your health status — this is a conversation to have with your prescriber, not a workaround to pursue independently.

What Affects Eligibility and Ongoing Access

Most GLP-1 prescribers apply the FDA's approved indications as their baseline criteria: BMI ≥ 30, or BMI ≥ 27 with at least one weight-related health condition (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN2), or pancreatitis.

GLP-1 medications require continued use to maintain weight loss — most patients who stop regain 2/3 of lost weight within a year. The long-term cost consideration is therefore ongoing rather than a one-time investment. Budgeting for 12–24 months of treatment as the evaluation period for whether the medication works for you is the standard clinical approach.

To find an obesity medicine specialist or primary care provider who prescribes GLP-1 medications in your area, browse providers by city or search for clinics near you. For context on whether a specialist visit is needed or your primary care provider can prescribe, see our guide on when to see a specialist vs. primary care.